NIGMS Technology Development Programs (R21 and R01): The technology development R21 and R01 funding opportunity announcements (FOAs) support technological innovations to advance biomedical research. Example technologies, which might originate from biomedical, engineering or physical sciences disciplines, include instruments, devices, processes, algorithms, software, chemicals, biomolecules, or cells that have potential value for generating new basic biomedical research. The FOAs support the earliest stages of technology development, establishing feasibility/proof of concept and prototype validation, and do not support applications that address new biological questions.
Proof of Concept and Value Exploratory Research / Technology Feasibility
Right arrow graphic.
Technology Development R21 Innovative Concepts
Down arrow graphic.
Prototype Validation Iterative Technology R&D / Validation Studies
Technology Development R01 Verification of Utility
Addressing Biological Question Applied technology R&D and Dissemination
Parent R01 Testing Biological Questions
Send your questions about the programs to the NIGMS tech dev contact mailbox.
This page last updated on 5/16/2022 3:35 PM
